BCDA
Price
$2.10
Change
-$0.17 (-7.49%)
Updated
Apr 3, 04:59 PM (EDT)
Capitalization
10.41M
SMMT
Price
$18.90
Change
-$1.56 (-7.62%)
Updated
Apr 3, 04:59 PM (EDT)
Capitalization
13.94B
35 days until earnings call
Ad is loading...

BCDA vs SMMT

Header iconBCDA vs SMMT Comparison
Open Charts BCDA vs SMMTBanner chart's image
BioCardia
Price$2.10
Change-$0.17 (-7.49%)
Volume$624
Capitalization10.41M
Summit Therapeutics
Price$18.90
Change-$1.56 (-7.62%)
Volume$69.57K
Capitalization13.94B
BCDA vs SMMT Comparison Chart
Loading...
BCDA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SMMT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BCDA vs. SMMT commentary
Apr 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BCDA is a Hold and SMMT is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 04, 2025
Stock price -- (BCDA: $2.27 vs. SMMT: $20.46)
Brand notoriety: BCDA and SMMT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BCDA: 87% vs. SMMT: 101%
Market capitalization -- BCDA: $10.41M vs. SMMT: $13.94B
BCDA [@Biotechnology] is valued at $10.41M. SMMT’s [@Biotechnology] market capitalization is $13.94B. The market cap for tickers in the [@Biotechnology] industry ranges from $299.64B to $0. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BCDA’s FA Score shows that 0 FA rating(s) are green whileSMMT’s FA Score has 2 green FA rating(s).

  • BCDA’s FA Score: 0 green, 5 red.
  • SMMT’s FA Score: 2 green, 3 red.
According to our system of comparison, SMMT is a better buy in the long-term than BCDA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BCDA’s TA Score shows that 5 TA indicator(s) are bullish while SMMT’s TA Score has 5 bullish TA indicator(s).

  • BCDA’s TA Score: 5 bullish, 4 bearish.
  • SMMT’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, SMMT is a better buy in the short-term than BCDA.

Price Growth

BCDA (@Biotechnology) experienced а -10.98% price change this week, while SMMT (@Biotechnology) price change was +2.87% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -8.57%. For the same industry, the average monthly price growth was -10.69%, and the average quarterly price growth was -14.76%.

Reported Earning Dates

BCDA is expected to report earnings on Aug 13, 2024.

SMMT is expected to report earnings on May 08, 2025.

Industries' Descriptions

@Biotechnology (-8.57% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SMMT($13.9B) has a higher market cap than BCDA($10.4M). SMMT YTD gains are higher at: 14.654 vs. BCDA (4.128). BCDA has higher annual earnings (EBITDA): -7.69M vs. SMMT (-212.51M). SMMT has more cash in the bank: 412M vs. BCDA (4.93M). BCDA has less debt than SMMT: BCDA (1.05M) vs SMMT (7.22M). BCDA has higher revenues than SMMT: BCDA (71K) vs SMMT (0).
BCDASMMTBCDA / SMMT
Capitalization10.4M13.9B0%
EBITDA-7.69M-212.51M4%
Gain YTD4.12814.65428%
P/E RatioN/A26.36-
Revenue71K0-
Total Cash4.93M412M1%
Total Debt1.05M7.22M14%
FUNDAMENTALS RATINGS
BCDA vs SMMT: Fundamental Ratings
BCDA
SMMT
OUTLOOK RATING
1..100
375
VALUATION
overvalued / fair valued / undervalued
1..100
76
Overvalued
95
Overvalued
PROFIT vs RISK RATING
1..100
10030
SMR RATING
1..100
10098
PRICE GROWTH RATING
1..100
6236
P/E GROWTH RATING
1..100
1006
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

BCDA's Valuation (76) in the null industry is in the same range as SMMT (95) in the Biotechnology industry. This means that BCDA’s stock grew similarly to SMMT’s over the last 12 months.

SMMT's Profit vs Risk Rating (30) in the Biotechnology industry is significantly better than the same rating for BCDA (100) in the null industry. This means that SMMT’s stock grew significantly faster than BCDA’s over the last 12 months.

SMMT's SMR Rating (98) in the Biotechnology industry is in the same range as BCDA (100) in the null industry. This means that SMMT’s stock grew similarly to BCDA’s over the last 12 months.

SMMT's Price Growth Rating (36) in the Biotechnology industry is in the same range as BCDA (62) in the null industry. This means that SMMT’s stock grew similarly to BCDA’s over the last 12 months.

SMMT's P/E Growth Rating (6) in the Biotechnology industry is significantly better than the same rating for BCDA (100) in the null industry. This means that SMMT’s stock grew significantly faster than BCDA’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BCDASMMT
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
90%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
85%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
86%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
86%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
88%
Bullish Trend 2 days ago
89%
Advances
ODDS (%)
Bullish Trend 7 days ago
79%
Bullish Trend 11 days ago
86%
Declines
ODDS (%)
Bearish Trend 3 days ago
89%
Bearish Trend 3 days ago
81%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
80%
N/A
Aroon
ODDS (%)
Bullish Trend 2 days ago
71%
Bearish Trend 2 days ago
87%
View a ticker or compare two or three
Ad is loading...
BCDA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SMMT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ADAP0.310.06
+22.00%
Adaptimmune Therapeutics plc
LBRDK87.572.04
+2.39%
Liberty Broadband Corp
EQX6.60-0.11
-1.64%
Equinox Gold Corp
ORC7.23-0.23
-3.08%
Orchid Island Capital
YFII.X242.189790-9.340912
-3.71%
DFI.Money cryptocurrency